Table 2. Presence of hrHPV after cryotherapy (cryo) by type of pre-cryo sample in women who were hrHPV-positive before cryotherapy.
| Post-cryo hrHPV status | Pre-cryo hrHPV-positive women | |
| Cells | Cells n (%) | Biopsy n (%) |
| Persistent, HPV16 | 9 (14.8) | 6 (12.2) |
| Persistent, other hr types 1 | 40 (65.6) | 32 (65.3) |
| New type(s) only 2 | 5 (8.2) | 6 (12.2) |
| Negative | 7 (11.5) | 5 (10.2) |
| Total | 61 | 493 |
Kenya, 61 HIV-positive women.
1
Persistence of at least one hr type but not HPV16.
2
In the absence of persistent hr types.
3
Does not include 12 women who were hrHPV-positive in cells but negative in biopsy.
hrHPV, high-risk human papillomavirus.